Retinoblastoma treatment: impact of the glycolytic inhibitor 2-deoxy-d-glucose on molecular genomics expression in LH_BETAT_AG retinal tumors

References

• PendergrassTWDavisSIncidence of retinoblastoma in the United StatesArch Ophthalmol198098120412107396771
   PubMedGoogle Scholar
• TamboliAPodgorMJHormJWThe incidence of retinoblastoma in the United States: 1974 through 1985Arch Ophthalmol19901081281322288550
   PubMedGoogle Scholar
• AbramsonDHRetinoblastoma in the 20th century: past success and future challenges. The Weisenfeld lectureInvest Ophthalmol Vis Sci2005462683269116043839
   PubMed Web of Science ®Google Scholar
• LaurieNASchin-ShihCDyerMATargeting MDM2 and MDMX in retinoblastomaCurr Cancer Drug Targets2007768969518045074
   PubMed Web of Science ®Google Scholar
• DeGregoriJJohnsonDGDistinct and overlapping roles for E2F family members in transcription, proliferation and apoptosisCurr Mol Med2006673974817100600
   PubMed Web of Science ®Google Scholar
• LiuYDeanDCTumor initiation via loss of cell contact inhibition versus Ras mutation: do all roads lead to EMT?Cell Cycle2010989790020160473
   PubMed Web of Science ®Google Scholar
• DunnJMPhillipsRABeckerAJGallieBLIdentification of germline and somatic mutations affecting the retinoblastoma geneScience1988241179718003175621
   PubMed Web of Science ®Google Scholar
• ClassonMHarlowEThe retinoblastoma tumour suppressor in development and cancerNat Rev Cancer2002291091712459729
   PubMed Web of Science ®Google Scholar
• ChakrabortySKhareSDorairajSKPrabhakaranVCPrakashDRKumarAIdentification of genes associated with tumorigenesis of retinoblastoma by microarray analysisGenomics20079034435317604597
   PubMed Web of Science ®Google Scholar
• LaurieNADonovanSLShihCSInactivation of the p53 pathway in retinoblastomaNature2006444616617080083
   PubMed Web of Science ®Google Scholar
• HoustonSKPinaYClarkeJRegional and temporal differences in gene expression of LH(BETA)T(AG) retinoblastoma tumorsInvest Ophthalmol Vis Sci2011525359536821571674
   PubMed Web of Science ®Google Scholar
• BoutridHJockovichMEMurrayTGTargeting hypoxia, a novel treatment for advanced retinoblastomaInvest Ophthalmol Vis Sci2008492799280518326690
   PubMed Web of Science ®Google Scholar
• BoutridHPinaYCebullaCMIncreased hypoxia following vessel targeting in a murine model of retinoblastomaInvest Ophthalmol Vis Sci2009505537554319578014
   PubMed Web of Science ®Google Scholar
• PiñaYHoustonSKMurrayTGFocal, periocular delivery of 2-deoxy-D-glucose as an adjuvant to chemotherapy for the treatment of advanced retinoblastomaInvest Ophthalmol Vis Sci201051126149615620702830
   PubMed Web of Science ®Google Scholar
• LampidisTJKurtogluMMaherJCEfficacy of 2-halogen substituted D-glucose analogs in blocking glycolysis and killing “hypoxic tumor cells”Cancer Chemother Pharmacol20065872573416555088
   PubMed Web of Science ®Google Scholar
• MaherJCKrishanALampidisTJGreater cell cycle inhibition and cytotoxicity induced by 2-deoxy-D-glucose in tumor cells treated under hypoxic vs aerobic conditionsCancer Chemother Pharmacol20045311612214605866
   PubMed Web of Science ®Google Scholar
• BermanELDonaldsonCEGiblinMMartinFJOutcomes in retinoblastoma, 1974–2005: the Children’s Hospital, WestmeadClin Experiment Ophthalmol20073551217300564
   PubMed Web of Science ®Google Scholar
• RouicLLAertsILevy-GabrielCConservative treatments of intraocular retinoblastomaOphthalmology200811581405141018222001
   PubMed Web of Science ®Google Scholar
• ScheflerACCicciarelliNFeuerWToledanoSMurrayTGMacular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablationOphthalmology200711416216917070578
   PubMed Web of Science ®Google Scholar
• WindleJJAlbertDMO’BrienJMRetinoblastoma in transgenic miceNature19903436656691689463
   PubMed Web of Science ®Google Scholar
• JockovichMEPinaYAlegretACebullaCFeuerWMurrayTGHeterogeneous tumor vasculature in retinoblastoma: implications for vessel targeting therapyRetina200828S81S8618317352
   PubMed Web of Science ®Google Scholar
• PiñaYBoutridHMurrayTGOphthalmic vasculature alterations following systemic chemotherapy and periocular Carboplatin treatment of advanced retinoblastomaJ Pediatr Ophthalmol Strabismus201047e1e5
   PubMedGoogle Scholar
• GentlemanRCCareyVJBatesDMBioconductor: open software development for computational biology and bioinformaticsGenome Biol20045R8015461798
   PubMed Web of Science ®Google Scholar
• TeamRDCR: A Language and Environment for Statistical ComputingVienna, AustriaR Foundation for Statistical Computing2010
   Google Scholar
• MaschekGSavarajNPriebeW2-deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivoCancer Res200464313414729604
   PubMed Web of Science ®Google Scholar
• MaherJCWangpaichitrMSavarajNKurtogluMLampidisTJHypoxia-inducible factor-1 confers resistance to the glycolytic inhibitor 2-deoxy-D-glucoseMol Cancer Ther2007673274117308069
   PubMed Web of Science ®Google Scholar
• PinaYBoutridHScheflerABlood vessel maturation in retinoblastoma tumors: spatial distribution of neovessels and mature vessels and its impact on ocular treatmentInvest Ophthalmol Vis Sci2009501020102418952925
   PubMed Web of Science ®Google Scholar
• Sanchez-ElsnerTBotellaLMVelascoBCorbiAAttisanoLBernabeuCSynergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expressionJ Biol Chem200127638527538
   Google Scholar
• ZhangHAkmanHOSmithELZhaoJMurphy-UllrichJEBatumanOACellular response to hypoxia involves signaling via Smad proteinsBlood20031012253226012411310
   PubMed Web of Science ®Google Scholar
• AkmanHOZhangHSiddiquiMASolomonWSmithELBatumanOAResponse to hypoxia involves transforming growth factor-beta2 and Smad proteins in human endothelial cellsBlood2001983324333111719370
   PubMed Web of Science ®Google Scholar
• KurtogluMMaherJCLampidisTJDifferential toxic mechanisms of 2-deoxy-D-glucose versus 2-fluorodeoxy-D-glucose in hypoxic and normoxic tumor cellsAntioxid Redox Signal200791383139017627467
   PubMed Web of Science ®Google Scholar
• KurtogluMPhilipsKLiuHBoiseLHLampidisTJHigh endoplasmic reticulum activity renders multiple myeloma cells hypersensitive to mitochondrial inhibitorsCancer Chemother Pharmacol6612914019779717
   PubMed Web of Science ®Google Scholar
• LiuHHuYPSavarajNPriebeWLampidisTJHypersensitization of tumor cells to glycolytic inhibitorsBiochemistry2001405542554711331019
   PubMed Web of Science ®Google Scholar
• LiuHSavarajNPriebeWLampidisTJHypoxia increases tumor cell sensitivity to glycolytic inhibitors: a strategy for solid tumor therapy (Model C)Biochem Pharmacol2002641745175112445863
   PubMed Web of Science ®Google Scholar
• MaherJCSavarajNPriebeWLiuHLampidisTJDifferential sensitivity to 2-deoxy-D-glucose between two pancreatic cell lines correlates with GLUT-1 expressionPancreas200530e34e3915714127
   PubMed Web of Science ®Google Scholar
• BertoutJAPatelSAFryerBHHeterozygosity for hypoxia inducible factor 1alpha decreases the incidence of thymic lymphomas in a p53 mutant mouse modelCancer Res2009693213322019293180
   PubMed Web of Science ®Google Scholar
• MiyazakiHWatabeTKitamuraTMiyazonoKBMP signals inhibit proliferation and in vivo tumor growth of androgen-insensitive prostate carcinoma cellsOncogene2004239326933515531927
   PubMed Web of Science ®Google Scholar
• Lorente-TrigosAVarnatFMelottiARuiz i AltabaABMP signaling promotes the growth of primary human colon carcinomas in vivoJ Mol Cell Biol2010231833221098050
   PubMed Web of Science ®Google Scholar
• MaschauerSPranteOHoffmannMDeichenJTKuwertTCharacterization of 18F-FDG uptake in human endothelial cells in vitroJ Nucl Med20044545546015001687
   PubMed Web of Science ®Google Scholar
• LoikeJDCaoLBrettJOgawaSSilversteinSCSternDHypoxia induces glucose transporter expression in endothelial cellsAm J Physiol1992263C326C3331514581
   PubMed Web of Science ®Google Scholar
• BuckAKReskeSNCellular origin and molecular mechanisms of 18F-FDG uptake: is there a contribution of the endothelium?J Nucl Med20044546146315001688
   PubMed Web of Science ®Google Scholar
• SoneHDeoBKKumagaiAKEnhancement of glucose transport by vascular endothelial growth factor in retinal endothelial cellsInvest Ophthalmol Vis Sci2000411876188410845612
   PubMed Web of Science ®Google Scholar
• MerchanJRKovacsKRailsbackJWAntiangiogenic activity of 2-deoxy-D-glucosePLoS One20105e1369921060881
   PubMed Web of Science ®Google Scholar
• CarmelietPAngiogenesis in health and diseaseNat Med2003965366012778163
   PubMed Web of Science ®Google Scholar
• RafiiSLydenDBenezraRHattoriKHeissigBVascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?Nat Rev Cancer2002282683512415253
   PubMed Web of Science ®Google Scholar
• ZiemssenFWegnerRWegnerJAnalysis of neovasculature in uveal melanoma by targeting the TGFbeta-binding receptor endoglin: is there prognostic relevance of proliferating endothelium?Graefes Arch Clin Exp Ophthalmol20062441124113116523306
   PubMed Web of Science ®Google Scholar
• FolkmanJSeminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesisN Engl J Med1995333175717637491141
   PubMed Web of Science ®Google Scholar
• RosenblattMIAzarDTAnti-angiogenic therapy: Prospects for treatment of ocular tumorsSemin Ophthalmol20062115116016912013
   PubMedGoogle Scholar
• StittAWGardinerTAAnti-angiogenic therapy for uveal melanoma – more haste, less speedBr J Ophthalmol20028636836911914199
   PubMed Web of Science ®Google Scholar
• YangHGrossniklausHECombined immunologic and anti-angiogenic therapy reduces hepatic micrometastases in a murine ocular melanoma modelCurr Eye Res20063155756216769615
   PubMed Web of Science ®Google Scholar
• ClarkAFMellonJLiXYInhibition of intraocular tumor growth by topical application of the angiostatic steroid anecortave acetateInvest Ophthalmol Vis Sci1999402158216210440274
   PubMed Web of Science ®Google Scholar
• BergersGBenjaminLETumorigenesis and the angiogenic switchNat Rev Cancer2003340141012778130
   PubMed Web of Science ®Google Scholar
• BergersGSongSMeyer-MorseNBergslandEHanahanDBenefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitorsJ Clin Invest20031111287129512727920
   PubMed Web of Science ®Google Scholar
• JockovichMEBajenaruMLPinaYRetinoblastoma tumor vessel maturation impacts efficacy of vessel targeting in the LHBETATAG mouse modelInvest Ophthalmol Vis Sci2007482476248217525173
   PubMed Web of Science ®Google Scholar
• PiñaYDecaturCMurrayTGAdvanced retinoblastoma treatment: targeting hypoxia by inhibition of the mammalian target of rapamycin (mTOR) in LHBETATAG retinal tumorsClin Ophthalmol2011533734321468343
   PubMedGoogle Scholar
• CreekmoreALWaltKASchultz-NortonJRThe role of retinoblastoma- associated proteins 46 and 48 in estrogen receptor alpha mediated gene expressionMol Cell Endocrinol2008291798618577416
   PubMed Web of Science ®Google Scholar
• GaoGGoffSPIsolation of suppressor genes that restore retrovirus susceptibility to a virus-resistant cell lineRetrovirology200413015453907
   PubMedGoogle Scholar
• WeihofenWABergerMChenHSaengerWHinderlichSStructures of human N-Acetylglucosamine kinase in two complexes with N-Acetylglucosamine and with ADP/glucose: insights into substrate specificity and regulationJ Mol Biol200636438839917010375
   PubMed Web of Science ®Google Scholar
• WoloskerHKlineDBianYMolecularly cloned mammalian glucosamine- 6-phosphate deaminase localizes to transporting epithelium and lacks oscillin activityFASEB J19981291999438414
   PubMed Web of Science ®Google Scholar
• BoardMColquhounANewsholmeEAHigh Km glucose- phosphorylating (glucokinase) activities in a range of tumor cell lines and inhibition of rates of tumor growth by the specific enzyme inhibitor mannoheptuloseCancer Res199555327832857614462
   PubMed Web of Science ®Google Scholar
• WellsLVossellerKHartGWA role for N-acetylglucosamine as a nutrient sensor and mediator of insulin resistanceCell Mol Life Sci20036022222812678487
   PubMed Web of Science ®Google Scholar
• ZacharaNEO’DonnellNCheungWDMercerJJMarthJDHartGWDynamic O-GlcNAc modification of nucleocytoplasmic proteins in response to stress. A survival response of mammalian cellsJ Biol Chem2004279301333014215138254
   PubMed Web of Science ®Google Scholar
• GianniDTauletNDerMardirossianCBokochGMc-Src-mediated phosphorylation of NoxA1 and Tks4 induces the reactive oxygen species (ROS)-dependent formation of functional invadopodia in human colon cancer cellsMol Biol Cell214287429820943948
   PubMed Web of Science ®Google Scholar
• SousaMSLatiniFRMonteiroHPCeruttiJMArginase 2 and nitric oxide synthase: pathways associated with the pathogenesis of thyroid tumorsFree Radic Biol Med49997100720542107
   PubMed Web of Science ®Google Scholar
• DongXTangHHessKRAbbruzzeseJLLiDGlucose metabolism gene polymorphisms and clinical outcome in pancreatic cancerCancer2011117348049120845477
   PubMed Web of Science ®Google Scholar
• PinaYBoutridHMurrayTGImpact of tumor-associated macrophages in LHBETATAG Mice on retinal tumor progression: relation to macrophage subtypeInvest Ophthalmol Vis Sci2010512671267720053982
   PubMed Web of Science ®Google Scholar
• HoustonSKPinaYClarkeJRegional and temporal differences in gene expression of LHBETATAG retinoblastoma tumorsInvest Ophthalmol Vis Sci20115285359536821571674
   PubMed Web of Science ®Google Scholar